[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@HerpesSupport_H Avatar @HerpesSupport_H HerpesUpdate

HerpesUpdate posts on X about novartis, roa, targets, 1m the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% countries XXXX% finance XXXX%

Social topic influence novartis 2.13%, roa 1.06%, targets 1.06%, 1m 1.06%, gsk plc 1.06%, united states 1.06%, market to 1.06%, future of 1.06%, proof of 1.06%, gilead sciences XXXX%

Top accounts mentioned or mentioned by @valuecarenatura @oyarzaballl @herpessupporth @cbdoge @nicolasada43008 @fredhutch @luisaco67237687 @herpesadvocate @nyckripto @rp_roger98

Top assets mentioned Novartis AG (NVS) GSK plc (GSK) Gilead Sciences, Inc. (GILD)

Top Social Posts #


Top posts by engagements in the last XX hours

"5 Pritelivir acts on the helicase-primase complex offering activity against both HSV-1 & HSV-2 potentially redefining therapy for patients who fail acyclovir valacyclovir or famciclovir"
X Link @HerpesSupport_H 2025-10-16T19:58Z 2528 followers, XXX engagements

"Herpes Simplex Pipeline 2025 DelveInsight report highlights major players reshaping HSV therapy: AiCuris (Pritelivir) Assembly Bio (ABI-5366) United BioPharma (UB-621) GSK Novartis Maruho BioNTech & more. New MOAs: helicase-primase inhibitors mAbs mRNA vaccines. ⚑ Hope in motion. πŸ‘‡πŸ‘‡"
X Link @HerpesSupport_H 2025-10-15T17:09Z 2512 followers, X engagements

"Herpes Simplex Pipeline 2025: MOA and ROA Insights Clinical Trials Status and Key Companies Involved by DelveInsight AiCuris United BioPharma Novartis Maruho Co. Ltd. GlaxoSmithKline πŸ‘‡πŸ‘‡"
X Link @HerpesSupport_H 2025-10-15T17:10Z 2529 followers, XXX engagements

"πŸ’‘AI in Sexual Health A new review finds image based AI can accurately identify anogenital dermatoses & STIs: Mpox: XX% sens / XX% spec Genital warts: XX% sens / XX% spec Psoriasis & Scabies: XX% sens / XX% spec Still early stage needs real world validation & bias control. πŸ‘‡πŸ‘‡ πŸ”—"
X Link @HerpesSupport_H 2025-10-12T22:34Z 2531 followers, XXX engagements

"1 Whats ABI-5366 A new helicase-primase inhibitor in development by Assembly Biosciences. Different from current drugs (like acyclovir/valacyclovir) because it targets the viral helicase-primase complex an enzyme critical for HSV replication with no human equivalent"
X Link @HerpesSupport_H 2025-10-10T17:39Z 2529 followers, XXX engagements

"🌍 STIs remain a major global challenge: ⚑ 1M+ curable cases daily 374M new infections yearly Herpes (HSV-2): 520M people living with it πŸŽ— HPV: 311K cervical cancer deaths each year Prevention vaccines & research matter"
X Link @HerpesSupport_H 2025-09-11T01:58Z 2531 followers, 1176 engagements

"🚨 Huge News: ABI-5366 Phase 1b Results Show XX% Reduction in HSV-2 Shedding. 🧡Thread. πŸ‘‡πŸ‘‡"
X Link @HerpesSupport_H 2025-10-10T17:39Z 2524 followers, 1333 engagements

"Future of United States Genital Herpes Treatment Market to hit US$ 1669.81 million by 2031 Advances in Antiviral Therapy Major Companies likes - Bausch Health Companies Inc. LNHC Inc. GSK plc. Camber Pharmaceuticals"
X Link @HerpesSupport_H 2025-09-28T23:26Z 2532 followers, 1047 engagements

"6 Aicuris previously developed Prevymis (letermovir) for CMV later licensed to Merck proving its antiviral track record"
X Link @HerpesSupport_H 2025-10-16T19:58Z 2529 followers, XXX engagements

"Theralases Ruvidar shows strong preclinical activity vs HSV-1 outperforming Acyclovir in cell & mouse models even against resistant strains. Promising but no human trials yet. Still early stage proof of concept not a cure. πŸ‘‡πŸ‘‡"
X Link @HerpesSupport_H 2025-10-12T22:25Z 2528 followers, XXX engagements

"🚨 Big move: Gilead Sciences bought 2.3M shares of Assembly Biosciences (ASMB) via private placement + warrants doubling its stake to 4.5M shares. Strategic interest in ASMBs pipeline πŸ‘€"
X Link @HerpesSupport_H 2025-10-04T21:14Z 2524 followers, XXX engagements